CI Financial (TSE:CIX – Get Free Report) was downgraded by Keefe, Bruyette & Woods from an “outperform” rating to a “market perform” rating in a note issued to investors on Tuesday,BayStreet.CA reports. They presently have a C$31.50 target price on the stock, up from their previous target price of C$28.00. Keefe, Bruyette & Woods’ target price would indicate a potential upside of 1.38% from the company’s previous close.
CIX has been the topic of a number of other research reports. Raymond James increased their price objective on CI Financial from C$27.00 to C$32.00 in a report on Tuesday. BMO Capital Markets increased their price target on shares of CI Financial from C$22.00 to C$25.00 in a research note on Friday, November 15th. TD Securities cut shares of CI Financial from a “buy” rating to a “sell” rating and upped their price objective for the stock from C$28.00 to C$32.00 in a report on Tuesday. Scotiabank raised their target price on CI Financial from C$25.00 to C$26.00 in a report on Friday, November 15th. Finally, Jefferies Financial Group boosted their price target on CI Financial from C$20.00 to C$27.00 and gave the stock a “buy” rating in a research report on Friday, November 1st. One research analyst has rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the company. According to MarketBeat, CI Financial has an average rating of “Hold” and a consensus price target of C$27.94.
View Our Latest Research Report on CIX
CI Financial Stock Performance
CI Financial Company Profile
CI Financial Corp. is a publicly owned asset management holding company. Through its subsidiaries, the firm manages separate client focused equity, fixed income, and alternative investments portfolios. It also manages mutual funds, hedge funds, and fund of funds for its clients through its subsidiaries.
See Also
- Five stocks we like better than CI Financial
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Most Effectively Use the MarketBeat Earnings Screener
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Stock Analyst Ratings and Canadian Analyst Ratings
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for CI Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CI Financial and related companies with MarketBeat.com's FREE daily email newsletter.